Cargando…
Efficacy and Safety of Transcutaneous Electrical Acupoint Stimulation to Treat Muscle Spasticity following Brain Injury: A Double-Blinded, Multicenter, Randomized Controlled Trial
OBJECTIVE: This study was aimed at evaluating the clinical efficacy and safety of transcutaneous electrical acupoint stimulation (TEAS) to treat muscle spasticity after brain injury (Chinese Clinical Trial Registry: ChiCTR-TRC-11001310). METHODS: A total of 60 patients with muscle spasticity after b...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314074/ https://www.ncbi.nlm.nih.gov/pubmed/25643051 http://dx.doi.org/10.1371/journal.pone.0116976 |
_version_ | 1782355288357076992 |
---|---|
author | Zhao, Wenli Wang, Chao Li, Zhongzheng Chen, Lei Li, Jianbo Cui, Weidong Ding, Shasha Xi, Qiang Wang, Fan Jia, Fei Xiao, Shuhua Guo, Yi Zhao, Ye |
author_facet | Zhao, Wenli Wang, Chao Li, Zhongzheng Chen, Lei Li, Jianbo Cui, Weidong Ding, Shasha Xi, Qiang Wang, Fan Jia, Fei Xiao, Shuhua Guo, Yi Zhao, Ye |
author_sort | Zhao, Wenli |
collection | PubMed |
description | OBJECTIVE: This study was aimed at evaluating the clinical efficacy and safety of transcutaneous electrical acupoint stimulation (TEAS) to treat muscle spasticity after brain injury (Chinese Clinical Trial Registry: ChiCTR-TRC-11001310). METHODS: A total of 60 patients with muscle spasticity after brain injury were randomized to the following 3 groups: 100, 2, and 0 Hz (sham) TEAS. The acupoints Hegu (LI4)—Yuji (LU10) and Zusanli (ST36)—Chengshan (BL57) on the injured side were stimulated at 0, 2, or 100 Hz, 5 times per week for 4 weeks. The patients were followed up for 1 and 2 months after the treatments. The effects of the treatments on muscle spasticity at the wrist, thumb, the other 4 fingers, elbow, shoulder, knee, and ankle were evaluated by the Modified Ashworth Scale, and the effects on disability were assessed by the Disability Assessment Scale. The walking capability was evaluated by the Holden functional ambulation classification score. The overall performance was assessed by the Global Assessment Scale score and the improved Barthel Index. The safety of the treatments administered was also monitored. RESULTS: The wrist spasticity was significantly reduced from baseline at weeks 2, 3, and 4 of treatment and at the 1- and 2-month follow-up visits in the 100 Hz group (P < 0.01). Compared with 2 Hz or sham TEAS, 100 Hz TEAS decreased wrist spasticity at weeks 2, 3, and 4 of treatment and 1 month after treatment (P < 0.001). The other endpoints were not affected by the treatments. No treatment-emergent adverse events were reported during treatments and follow-up visits. CONCLUSIONS: TEAS appears to be a safe and effective therapy to relieve muscle spasticity after brain injury, although large-scale studies are required to further verify the findings. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR-TRC-11001310 http://www.chictr.org |
format | Online Article Text |
id | pubmed-4314074 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-43140742015-02-13 Efficacy and Safety of Transcutaneous Electrical Acupoint Stimulation to Treat Muscle Spasticity following Brain Injury: A Double-Blinded, Multicenter, Randomized Controlled Trial Zhao, Wenli Wang, Chao Li, Zhongzheng Chen, Lei Li, Jianbo Cui, Weidong Ding, Shasha Xi, Qiang Wang, Fan Jia, Fei Xiao, Shuhua Guo, Yi Zhao, Ye PLoS One Research Article OBJECTIVE: This study was aimed at evaluating the clinical efficacy and safety of transcutaneous electrical acupoint stimulation (TEAS) to treat muscle spasticity after brain injury (Chinese Clinical Trial Registry: ChiCTR-TRC-11001310). METHODS: A total of 60 patients with muscle spasticity after brain injury were randomized to the following 3 groups: 100, 2, and 0 Hz (sham) TEAS. The acupoints Hegu (LI4)—Yuji (LU10) and Zusanli (ST36)—Chengshan (BL57) on the injured side were stimulated at 0, 2, or 100 Hz, 5 times per week for 4 weeks. The patients were followed up for 1 and 2 months after the treatments. The effects of the treatments on muscle spasticity at the wrist, thumb, the other 4 fingers, elbow, shoulder, knee, and ankle were evaluated by the Modified Ashworth Scale, and the effects on disability were assessed by the Disability Assessment Scale. The walking capability was evaluated by the Holden functional ambulation classification score. The overall performance was assessed by the Global Assessment Scale score and the improved Barthel Index. The safety of the treatments administered was also monitored. RESULTS: The wrist spasticity was significantly reduced from baseline at weeks 2, 3, and 4 of treatment and at the 1- and 2-month follow-up visits in the 100 Hz group (P < 0.01). Compared with 2 Hz or sham TEAS, 100 Hz TEAS decreased wrist spasticity at weeks 2, 3, and 4 of treatment and 1 month after treatment (P < 0.001). The other endpoints were not affected by the treatments. No treatment-emergent adverse events were reported during treatments and follow-up visits. CONCLUSIONS: TEAS appears to be a safe and effective therapy to relieve muscle spasticity after brain injury, although large-scale studies are required to further verify the findings. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR-TRC-11001310 http://www.chictr.org Public Library of Science 2015-02-02 /pmc/articles/PMC4314074/ /pubmed/25643051 http://dx.doi.org/10.1371/journal.pone.0116976 Text en © 2015 Zhao et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Zhao, Wenli Wang, Chao Li, Zhongzheng Chen, Lei Li, Jianbo Cui, Weidong Ding, Shasha Xi, Qiang Wang, Fan Jia, Fei Xiao, Shuhua Guo, Yi Zhao, Ye Efficacy and Safety of Transcutaneous Electrical Acupoint Stimulation to Treat Muscle Spasticity following Brain Injury: A Double-Blinded, Multicenter, Randomized Controlled Trial |
title | Efficacy and Safety of Transcutaneous Electrical Acupoint Stimulation to Treat Muscle Spasticity following Brain Injury: A Double-Blinded, Multicenter, Randomized Controlled Trial |
title_full | Efficacy and Safety of Transcutaneous Electrical Acupoint Stimulation to Treat Muscle Spasticity following Brain Injury: A Double-Blinded, Multicenter, Randomized Controlled Trial |
title_fullStr | Efficacy and Safety of Transcutaneous Electrical Acupoint Stimulation to Treat Muscle Spasticity following Brain Injury: A Double-Blinded, Multicenter, Randomized Controlled Trial |
title_full_unstemmed | Efficacy and Safety of Transcutaneous Electrical Acupoint Stimulation to Treat Muscle Spasticity following Brain Injury: A Double-Blinded, Multicenter, Randomized Controlled Trial |
title_short | Efficacy and Safety of Transcutaneous Electrical Acupoint Stimulation to Treat Muscle Spasticity following Brain Injury: A Double-Blinded, Multicenter, Randomized Controlled Trial |
title_sort | efficacy and safety of transcutaneous electrical acupoint stimulation to treat muscle spasticity following brain injury: a double-blinded, multicenter, randomized controlled trial |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314074/ https://www.ncbi.nlm.nih.gov/pubmed/25643051 http://dx.doi.org/10.1371/journal.pone.0116976 |
work_keys_str_mv | AT zhaowenli efficacyandsafetyoftranscutaneouselectricalacupointstimulationtotreatmusclespasticityfollowingbraininjuryadoubleblindedmulticenterrandomizedcontrolledtrial AT wangchao efficacyandsafetyoftranscutaneouselectricalacupointstimulationtotreatmusclespasticityfollowingbraininjuryadoubleblindedmulticenterrandomizedcontrolledtrial AT lizhongzheng efficacyandsafetyoftranscutaneouselectricalacupointstimulationtotreatmusclespasticityfollowingbraininjuryadoubleblindedmulticenterrandomizedcontrolledtrial AT chenlei efficacyandsafetyoftranscutaneouselectricalacupointstimulationtotreatmusclespasticityfollowingbraininjuryadoubleblindedmulticenterrandomizedcontrolledtrial AT lijianbo efficacyandsafetyoftranscutaneouselectricalacupointstimulationtotreatmusclespasticityfollowingbraininjuryadoubleblindedmulticenterrandomizedcontrolledtrial AT cuiweidong efficacyandsafetyoftranscutaneouselectricalacupointstimulationtotreatmusclespasticityfollowingbraininjuryadoubleblindedmulticenterrandomizedcontrolledtrial AT dingshasha efficacyandsafetyoftranscutaneouselectricalacupointstimulationtotreatmusclespasticityfollowingbraininjuryadoubleblindedmulticenterrandomizedcontrolledtrial AT xiqiang efficacyandsafetyoftranscutaneouselectricalacupointstimulationtotreatmusclespasticityfollowingbraininjuryadoubleblindedmulticenterrandomizedcontrolledtrial AT wangfan efficacyandsafetyoftranscutaneouselectricalacupointstimulationtotreatmusclespasticityfollowingbraininjuryadoubleblindedmulticenterrandomizedcontrolledtrial AT jiafei efficacyandsafetyoftranscutaneouselectricalacupointstimulationtotreatmusclespasticityfollowingbraininjuryadoubleblindedmulticenterrandomizedcontrolledtrial AT xiaoshuhua efficacyandsafetyoftranscutaneouselectricalacupointstimulationtotreatmusclespasticityfollowingbraininjuryadoubleblindedmulticenterrandomizedcontrolledtrial AT guoyi efficacyandsafetyoftranscutaneouselectricalacupointstimulationtotreatmusclespasticityfollowingbraininjuryadoubleblindedmulticenterrandomizedcontrolledtrial AT zhaoye efficacyandsafetyoftranscutaneouselectricalacupointstimulationtotreatmusclespasticityfollowingbraininjuryadoubleblindedmulticenterrandomizedcontrolledtrial |